Styris Pharma Private Limited
About Styris Pharma Private Limited
Data last updated:
Styris Pharma Private Limited is a private limited company based in Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2000PTC034175. Its GSTIN is 36AAACL5819K1ZA (Telangana).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹9 Lakh. It was formerly known as Lorven Pharma Private Limited. It is led by directors Kodanda Ramu Pilla (Managing Director) and Venkata Nalini Pilla.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 1 – 4 – 69/2 1st Floor Street No 8 Habsiguda Hyderabad, Telangana, India – 500007.
As per the financials filed for FY 2021, the company reported a revenue of ₹71.98 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹1.02 Lakh (net margin 1.4%) and EBITDA of ₹2.39 Lakh (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 3% over five years.
As per MCA filings, the company has satisfied charges of ₹21.33 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1 – 4 – 69/2 1st Floor Street No 8 Habsiguda Hyderabad, Telangana, India – 500007
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Styris Pharma Private Limited
The main business activity of Styris Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Styris Pharma Private Limited FY 2021 filings available
Styris Pharma Private Limited reported revenue of ₹71.98 Lakh (down 32% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Styris Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 32% fall in the latest year. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Styris Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.02 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Styris Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Styris Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Styris Pharma Private Limited
Styris Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prosum Medical Private Limited | ₹72.34 Lakh (FY 2025) | •••• | •••• | 126.0% | •••• | Mohali, Punjab, India |
| MHS Pharmaceuticals Private Limited | ₹72.2 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Hyderabad, Telangana, India |
| Gennex Health Care Private Limited | ₹72.19 Lakh (FY 2023) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Voluenta Pharmaceuticals Private Limited | ₹72.03 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | New Delhi, Delhi, India |
| Pan Bioscience Private Limited | ₹72.01 Lakh (FY 2019) | •••• | •••• | -51.0% | •••• | Chennai, Tamil Nadu, India |
| Styris Pharma Private Limited this company | ₹71.98 Lakh (FY 2021) | •••• | •••• | -32.0% | •••• | Telangana, India |
| Newmark Biosciences Private Limited | ₹71.96 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Bareilly, Uttar Pradesh, India |
| Midlife Biosciences Private Limited | ₹71.68 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Kanpur, Uttar Pradesh, India |
| Dorris Pharmaceuticals Private Limited | ₹71.6 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Delhi, India |
| PPJ Pharma Private Limited | ₹71.57 Lakh (FY 2025) | •••• | •••• | 4978.0% | •••• | Thane, Maharashtra, India |
| Abisai Farma Private Limited | ₹71.46 Lakh (FY 2024) | •••• | •••• | 76.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Styris Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Styris Pharma Private Limited
Styris Pharma Private Limited is audited by S B S MURTHY & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S B S MURTHY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Styris Pharma Private Limited
Styris Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kodanda Ramu Pilla | Managing Director | 03 Apr 2000 | 26 Years 6 Months | Current |
| Venkata Nalini Pilla | Director | 11 Feb 2013 | 13 Years 7 Months | Current |
Ownership and Shareholding of Styris Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Styris Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2008 | City Union Bank Limited | ₹20 Lakh | Satisfied |
| 28 Feb 2006 | Sri Lakshmi Vilas Bank Ltd. | ₹1.33 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Styris Pharma Private Limited
Employment history and EPFO contributions of people linked to Styris Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Styris Pharma Private Limited
Styris Pharma has one previous CIN (Corporate Identification Number): U24239AP2000PTC034175. The current CIN is U24239TG2000PTC034175, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2000PTC034175 | Current |
| U24239AP2000PTC034175 | Previous |
Recent Activity on Styris Pharma Private Limited
Styris Pharma Private Limited has 4 board changes on record since 2000: 2 appointments and 2 cessations. The latest: Venkata Nalini Pilla ceased to be Additional Director on 30 Sep 2013.
Credit Ratings, Litigation & Regulatory Alerts for Styris Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Styris Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Styris Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Styris Pharma Private Limited
Styris Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACL5819K1ZA | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Styris Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Styris Pharma Private Limited
Styris Pharma is an active private limited company based in Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 April 2000 (26+ years old) and is registered under CIN U24239TG2000PTC034175.
Styris Pharma reported revenue of ₹71.98 Lakh for FY 2021 (down 32% YoY).
Styris Pharma has 2 current directors:
- Kodanda Ramu Pilla - Managing Director
- Venkata Nalini Pilla - Director
Styris Pharma reported a net profit of ₹1.02 Lakh (net margin 1.4%) and EBITDA of ₹2.39 Lakh (EBITDA margin 3.3%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Styris Pharma is -6% over three years and -3% over five years. In the latest year (FY 2021) revenue fell 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Styris Pharma is 36AAACL5819K1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Styris Pharma is U24239TG2000PTC034175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styris Pharma was incorporated on 03 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Styris Pharma by revenue are Prosum Medical Private Limited, MHS Pharmaceuticals Private Limited, Gennex Health Care Private Limited, Voluenta Pharmaceuticals Private Limited, Pan Bioscience Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Venkata Nalini Pilla ceased to be Additional Director on 30 Sep 2013. Kanaka Lakshmi Saladi ceased to be Director on 11 Feb 2013. Venkata Nalini Pilla was appointed as Director on 11 Feb 2013. Styris Pharma has 4 board changes on record in total.
The registered office of Styris Pharma is at 1 – 4 – 692 1st Floor Street No 8 Habsiguda Hyderabad, Telangana, India – 500007.